Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Analysts Make the Case for Small-Cap Biotech Stocks This Fall (INMB, DVAX, SAVA, ICPT, IMGN, ATRX)

IBB : 171.48 (-0.60%)
MRNA : 430.71 (-2.26%)
INMB : 17.90 (-0.94%)
ATRX : 0.1700 (+21.43%)
SAVA : 45.60 (+3.75%)
DVAX : 14.35 (-0.62%)
ICPT : 15.65 (+1.56%)
IMGN : 5.66 (-0.35%)
Sutro (STRO) Ovarian Cancer Drug Gets FDA's Fast Track Tag

Sutro's (STRO) investigational antibody-drug conjugate therapy, STRO-002, gets Fast Track designation from the FDA for advanced ovarian cancer.

BMY : 60.97 (-0.42%)
MRNA : 430.71 (-2.26%)
IMGN : 5.66 (-0.35%)
STRO : 19.97 (-0.05%)
ImmunoGen is Now Oversold (IMGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

IMGN : 5.66 (-0.35%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on July 30, 2021 the compensation committee of the Company's...

IMGN : 5.66 (-0.35%)
ImmunoGen (IMGN) Q2 Loss Narrower Than Expected, Revenues Lag

ImmunoGen (IMGN) reports narrower-than-expected loss but misses revenue estimates.

RHHBY : 46.3100 (-1.09%)
BMY : 60.97 (-0.42%)
MRK : 71.15 (-1.14%)
IMGN : 5.66 (-0.35%)
ImmunoGen (IMGN) Reports Q2 Loss, Misses Revenue Estimates

ImmunoGen (IMGN) delivered earnings and revenue surprises of 16.67% and -10.44%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

IMGN : 5.66 (-0.35%)
ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results

--Top-line Data from Pivotal SORAYA Trial on Track for Q4 Release

IMGN : 5.66 (-0.35%)
Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for

ImmunoGen (IMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IMGN : 5.66 (-0.35%)
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2021 Operating Results

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m....

IMGN : 5.66 (-0.35%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on June 30, 2021 the compensation committee of the Company's...

IMGN : 5.66 (-0.35%)

Barchart Exclusives

US Dollar Index Bulls Toot Their Own Horns
The short-term rally by the US dollar index may not make a lot of sense, but at least it's consistent. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar